Journal
NATURE MEDICINE
Volume 17, Issue 7, Pages 784-785Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm0711-784
Keywords
-
Funding
- NCI NIH HHS [P30 CA016058] Funding Source: Medline
Ask authors/readers for more resources
A new combinatorial approach harnesses the power of immuno- and virotherapy in a vesicular stomatitis virus (VSV) vector carrying a cDNA library that expresses normal human prostate antigens, thus providing proof of principle that this vaccine can induce prostate tumor rejection in mice (pages 854-859). This strategy might bypass many of the issues associated with conventional cancer immuno- or virotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available